The 12th Conference on HIV Science (IAS 2023) will take place in Brisbane, Australia, from July 23 to 26, 2023, presenting up-to-date information from research related to the topic. Through its open and inclusive program, the meeting establishes the gold standard of science around HIV/AIDS, disseminating highly diversified works from several areas.

With a program based on symposia, satellite symposia, presentations and posters supported by the world’s leading experts, the event will address innovative technologies such as long-acting injectable cabotegravir (CAB-LA) for anti-retroviral treatment and for pre-exposure prophylaxis (PrEP), as well as topics related to mental health, sexually transmitted infections, testing, novel programmatic approaches, innovation and integrated interventions, basic science, among other topics.

Always present at the main international foraon HIV, AIDS and PrEP, the ImPrEP CAB Brasil project, in partnership with Unitaid and the Brazilian Ministry of Health, will be at IAS 2023. The highlight will be the conduction of the satellite symposium “Preparedness for CAB-LA PrEP implementation – the ImPrEP CAB Brasil Project”. The project will also have oral and poster presentations.

Another highlight of the IAS 2023 program will be the satellite symposium organized by Evandro Chagas National Institute of Infectious Diseases/Fiocruz in partnership with the State University of Bahia and the Federal University of Bahia: “Innovative and real-time testing, care, and surveillance of Covid-19 response in an evolving pandemic in local contexts”.

Check out the ImPrEP program and INI symposium:

Satellite Symposium “Preparedness for CAB-LA PrEP implementation – the ImPrEP CAB Brasil Project” (SAT034, room M3, channel 5)

July 24, Monday (available to conference registrants from 7.30 AM – Australia time)

Topics and participants:

– Opening remarks, with with Dráurio Barreira (Department of HIV/AIDS, Tuberculosis, Viral Hepatitis and Sexually Transmitted Infections, of the Brazilian Ministry of Health) and Valdiléa Veloso (Evandro Chagas National Institute of Infectious Diseases, – Oswaldo Cruz Foundation – INI/Fiocruz);

– ImPrEP HIV seroincidence sub-study, with Thiago Torres (INI/Fiocruz);

– Preferences for PrEP in Brazil – Discrete-Choice Experiment study, with Cláudia Pereira (Sérgio Arouca National School of Public Health, Fiocruz);

– Preparation for the implementation of PrEP with CAB-LA in Brazil, with Beatriz Grinsztejn (INI/Fiocruz);

– Final remarks, with Omar Sued (Pan American Health Organization).

Oral presentation

– Racial disparities in HIV incidence and PrEP non-adherence among gay and other men who have sex with men (MSM) and transgender women (TGW) using oral PrEP in Brazil: ImPrEP study, with Lucilene Freitas, from INI/Fiocruz, and ImPrEP Study Group (OALBX0204);

Posters

– Characteristics of HIV seroconversions in ImPrEP, a large PrEP implementation study in Latin America, with Brenda Hoagland, INI/Fiocruz, et al (MOPEC13);

– Process mapping to support delivery of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis within Public Health Systems: the ImPrEP CAB Brasil study, with Mirian Cohen, from INI/Fiocruz, and ImPrEP CAB Brasil Study Group (EPE0810);

– Factors associated with incident sexually transmitted infections (IST) among men who have sex with men (MSM) and transgender women (TGW) on oral PrEP in Latin America: the ImPrEP study, with Mayara Secco, from INI/Fiocruz, and ImPrEP Study Group (LBPEC01).

Satellite Symposium Innovative and real-timetesting, care, and surveillance of Covid-19 response in an evolving pandemic in local contexts (SAT 044, Plaza Ballroom, channel 3)

July 25, Tuesday, (available to conference registrants from 7:30 AM – Australia time)

Topics and participants:

– Opening – Overview, with an Unitaid  representative;

-Covid-19 epidemiologic profile among highly vulnerable socioeconomic neighborhoods in two Brazilian capitals, with Inês Dourado (Federal University of Bahia) and Valdiléa Veloso (INI/Fiocruz);

– Implementation of a digital platform linking to Covid-19 testing in the primary healthcare settings in two Brazilian capitals, with Thais Aranha Rossi and Laio Magno (State University of Bahia);

– Knowledge and usability of the self-test for Covid-19 in two Brazilian capitals, with Thiago Torres (INI/Fiocruz);

– Lessons learned based on Covid-19 for future pandemics: testing, surveillance, and telehealth, with Purvi Shah (World Health Organization).